Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-22-000005

Director acquired 1,265 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dubin Glenn Director 2022-10-03 Grant or award +1,265 $8.69 $10,993 3,510 D
Loading xslF345X03/wf-form4_166492113147782.xml…